Nautilus Biotechnology, Inc. (NAUT) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Nautilus Biotechnology, Inc. (NAUT) closed at USD 2.16 on 2026-10-14, a change of +51 % over the past year, with a market capitalization of USD 274.49M.

Nautilus Biotechnology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Nautilus Biotechnology, Inc. key figures

Previous close

USD 2.16 (2026-10-14)

1-year change

+51 %

Market cap

USD 274.49M

Enterprise value

USD 218.66M

P/E ratio (trailing)

-4.80

P/E ratio (forward)

-2.92

EPS (trailing)

-0.45

EPS (forward)

-0.74

PEG ratio

n/a

Price to book

2.10

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.14

Employees

127

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Nautilus Biotechnology, Inc. and compare it with other stocks.